Characterization of the interaction of zopiclone with γ-aminobutyric acid type A receptors

Molecular Pharmacology

Volumn 58, Issue 4, 2000, Pages 756-762

  Davies, Martin ^a   Newell, J Glen ^a   Derry, Jason M C ^a   Martin, Ian L ^b   Dunn, Susan M J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 6 BENZYLOXY 4 METHOXYMETHYL BETA CARBOLINE 3 CARBOXYLIC ACID ETHYL ESTER; BENZODIAZEPINE; COMPLEMENTARY DNA; DIAZEPAM; FLUMAZENIL; FLUNITRAZEPAM; HYPNOTIC AGENT; LIGAND; TRITIUM; ZOPICLONE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CEREBELLUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; LIGAND BINDING; NEUROTRANSMISSION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; XENOPUS LAEVIS;

EID: 0033802954     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.4.756     Document Type: Article

References (35)

1. International union of pharmacology. XV. Subtypes of γ-aminobutyric acid(A) receptors: Classification on the basis of subunit structure and receptor function
2. 3H]Ro15-1788 in the mouse brain: Preferential affinity of zolpidem for the omega1 subtype
3. Differences between the cyclopyrrolones (suriclone and zopiclane) and benzodiazepine binding in rat hippocampus photolabelled membranes
4. Stereochemical features controlling binding and intrinsic activity properties of benzodiazepine-receptor ligands
5. Photoaffinity labeling of the benzodazepine receptor compromises the recognition site but not its effector mechanism
6. Benzodiazepine receptor binding of nonbenzodiazepines in vivo; alpidem, zolpidem and zopiclone
7. The effect of cyclopyrrolones of GABA(A) receptor function is different from that of benzodiazepines
8. Molecular biology of the GABA(A) receptor: Functional domains implicated by mutational analysis
9. Structural requirements for ligand interaction at the benzodiazepine recognition site of the GABA(A) receptor
10. The mechanism of action of zopiclone
11. 3H]flunitrazepam is histidine 102 of the alpha subunit
12. Mutagenesis of the rat α1 subunit of the γ-aminobutyric acid(A) receptor reveals the importance of residue 101 in determining the allosteric effects of benzodiazepine site ligands
13. Expression and properties of recombinant α1β2γ2 and α5β2γ2 forms of the rat GABA(A) receptor
14. Conformational shifts at the benzodiazepine receptor related to the binding of agonists, antagonists, and inverse agonists
15. A review of recently developed ligands for neuronal benzodiazepine receptors and their pharmacological activities
16. Zopiclone: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic
17. Expression and pharmacology of human GABA(A) receptor containing γ3 subunits
18. Pharmacological and clinical studies of cyclopyrrolones: Zopiclone and suriclone
19. Distinction of benzodiazepine agonists from antagonists by photoaffinity labeling of benzodazepine receptors in vitro
20. Future directions in anxiolytic pharmacology
21. 35S-TBPS) binding to rat cerebral cortex membranes
22. Impact of β and γ variants on ligand-binding properties of γ-aminobutyric acid type A receptors
23. Photoaffinity labeling of the benzodiazepine binding site of α1β3γ2 γ-aminobutyric acid(A) receptors with flunitrazepam identifies a subset of ligands that interact directly with his102 of the α subunit and predicts orientation of these within the benzodiazepine pharmacophore
24. Propofol and flurazepam act synergistically to potentiate GABA(A) receptor activation in human recombinant receptors
25. Recent developments in the behavioural pharmacology of benzodiazepine (omega) receptors: Evidence for the functional significance of receptor subtypes
26. Structure and pharmacology of γ-aminobutyric acid(A) receptor subtypes
27. The benzodiazepine binding site of GABA(A) receptors
28. Benzodazepine receptor ligand actions on GABA responses: Benzodiazepines, CL 218872, zopiclone
29. Photoaffinity labeling of benzodiazepine receptors causes altered agonist-antagonist interactions
30. γ-Aminobutyric acid(A) receptors displaying association of γ3-subunits with β(2/3) and different α-subunits exhibit unique pharmacological profiles
31. Anxiolytic cyclopyrrolones zopiclone and suriclone bind to a novel site linked allosterically to benzodiazepine receptors
32. Beyond benzodiazepines: Alternative pharmacologic agents for the treatment of insomnia
33. A single histidine in GABA(A) receptors is essential for benzodiazepine agonist binding
34. Molecular and functional diversity of the expanding GABA-A receptor gene family
35. Development of a comprehensive pharmacophore model for the benzodiazepine receptor